US 9827326
Polymer-sunitinib conjugates
granted A61KA61K31/404A61K47/58
Quick answer
US patent 9827326 (Polymer-sunitinib conjugates) held by Nektar Therapeutics expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/404, A61K47/58, A61K47/60, A61P